Mark J. Ratain to Product Surveillance, Postmarketing
This is a "connection" page, showing publications Mark J. Ratain has written about Product Surveillance, Postmarketing.
Connection Strength
0.228
-
Project Optimus: Is the US Food and Drug Administration Waiving Dose Optimization for Orphan Drugs? JAMA Oncol. 2023 11 01; 9(11):1489-1490.
Score: 0.228